Edwards Lifesciences Corporation

EW · NYSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$3,045,200$1,132,300$769,000$862,800
Short-Term Investments$930,700$500,500$446,300$604,000
Receivables$727,400$828,100$699,100$664,900
Inventory$1,086,700$903,500$875,500$726,700
Other Curr. Assets$495,400$671,300$305,900$322,300
Total Curr. Assets$6,285,400$4,035,700$3,095,800$3,180,700
Property Plant & Equip (Net)$1,784,200$1,675,400$1,725,100$1,638,700
Goodwill$1,776,700$1,145,100$1,164,300$1,167,900
Intangibles$1,176,600$399,400$285,200$323,600
Long-Term Investments$307,900$583,900$1,239,000$1,834,200
Tax Assets$992,100$749,400$484,000$246,700
Other NC Assets$732,400$774,300$299,100$110,800
Total NC Assets$6,769,900$5,327,500$5,196,700$5,321,900
Other Assets$0$0$0$0
Total Assets$13,055,300$9,363,200$8,292,500$8,502,600
Liabilities
Payables$197,400$186,600$201,900$204,500
Short-Term Debt$23,400$22,900$25,500$25,500
Tax Payable$374,700$106,500$96,200$99,500
Deferred Revenue$53,700$0$0$0
Other Curr. Liab.$856,000$879,400$698,800$702,800
Total Curr. Liab.$1,505,200$1,195,400$1,022,400$1,032,300
LT Debt$676,600$662,200$665,800$664,800
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$810,600$786,200$797,600$969,600
Total NC Liab.$1,487,200$1,448,400$1,463,400$1,634,400
Other Liabilities$0$0$0$0
Cap. Leases$102,300$88,100$95,000$94,600
Total Liabilities$2,992,400$2,643,800$2,485,800$2,666,700
Equity
Pref Stock$0$0$0$0
Common Stock$654,800$650,500$646,300$642,000
Retained Earnings$13,167,000$8,992,400$7,590,000$6,068,100
AOCI-$244,500-$242,800-$254,900-$157,700
Other Equity-$3,578,900-$2,750,100-$2,174,700-$716,500
Total Equity$9,998,400$6,650,000$5,806,700$5,835,900
Supplemental Information
Minority Interest$64,500$69,400$0$0
Total Liab. & Tot. Equity$13,055,300$9,363,200$8,292,500$8,502,600
Net Debt-$2,345,200-$447,200-$77,700-$172,500